We are live on ! Find out more
Assenagon Asset Management

Assenagon Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 50.57%
This Fund
S&P 500
This Quarter Est. Return
+12.27%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
AUM
$15.9B
AUM Growth
+$961M
Cap. Flow
-$622M
Cap. Flow %
-3.91%
Top 10 Hldgs %
35.94%
Holding
1,046
New
237
Increased
269
Reduced
219
Closed
304

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$654M
2
AGN
Allergan plc
AGN
+$320M
3
VZ icon
Verizon
VZ
+$255M
4
INTC icon
Intel
INTC
+$231M
5
CELG
Celgene Corp
CELG
+$224M

Sector Composition

Rank Sector Weight
1 Technology 14.12%
2 Communication Services 9.99%
3 Consumer Discretionary 8.74%
4 Healthcare 8.31%
5 Industrials 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCX icon
726
AMC Global Media
AMCX
$489M
$205K ﹤0.01%
+5,190
New +$218K
MODN
727
DELISTED
MODEL N, INC.
MODN
$205K ﹤0.01%
5,851
-122,199
-95% -$3.72M
RM icon
728
Regional Management Corp
RM
$303M
$202K ﹤0.01%
6,742
-16,878
-71% -$512K
BEAT
729
DELISTED
BioTelemetry, Inc.
BEAT
$202K ﹤0.01%
+4,370
New +$189K
MRSN
730
DELISTED
Mersana Therapeutics
MRSN
$196K ﹤0.01%
+1,371
New +$100K
AKRX
731
DELISTED
Akorn Inc
AKRX
$194K ﹤0.01%
129,642
-102,786
-44% -$388K
ACCO icon
732
Acco Brands
ACCO
$407M
$191K ﹤0.01%
20,448
-13,253
-39% -$125K
BRKL
733
DELISTED
Brookline Bancorp
BRKL
$169K ﹤0.01%
10,256
-5,238
-34% -$82.5K
AGRO icon
734
Adecoagro
AGRO
$1.36B
$166K ﹤0.01%
+19,800
New +$133K
AMRX icon
735
Amneal Pharmaceuticals
AMRX
$5.79B
$164K ﹤0.01%
34,064
-300,923
-90% -$1.05M
CAMP
736
DELISTED
CalAmp Corp.
CAMP
$153K ﹤0.01%
693
-7,907
-92% -$1.93M
LSAK icon
737
Lesaka Technologies
LSAK
$420M
$134K ﹤0.01%
+36,120
New +$120K
TRUE
738
DELISTED
TrueCar
TRUE
$127K ﹤0.01%
+26,800
New +$112K
INWK
739
DELISTED
InnerWorkings, Inc.
INWK
$82K ﹤0.01%
14,900
-184,368
-93% -$894K
AKBA icon
740
Akebia Therapeutics
AKBA
$252M
$77K ﹤0.01%
+12,146
New +$57.7K
LQDT icon
741
Liquidity Services
LQDT
$1.32B
$67K ﹤0.01%
11,308
-63,592
-85% -$409K
ARC
742
DELISTED
ARC Document Solutions, Inc.
ARC
$32K ﹤0.01%
22,868
-41,142
-64% -$53.6K
ABT icon
743
Abbott
ABT
$187B
-451,531
Closed -$37.8M
ACAD icon
744
Acadia Pharmaceuticals
ACAD
$5.03B
-19,822
Closed -$713K
AEIS icon
745
Advanced Energy
AEIS
$13B
-13,998
Closed -$804K
AGEN
746
Agenus
AGEN
$290M
-1,973
Closed -$100K
AIN icon
747
Albany International
AIN
$1.78B
-2,760
Closed -$249K
AIT icon
748
Applied Industrial Technologies
AIT
$13.3B
-28,707
Closed -$1.63M
AIZ icon
749
Assurant
AIZ
$14.3B
-13,427
Closed -$1.69M
ALGT icon
750
Allegiant Air
ALGT
$2.57B
-29,795
Closed -$4.46M

Similar funds

Assenagon Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Assenagon Asset Management held 1,046 positions worth $15.9B, up 6.4% from $14.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Assenagon Asset Management withdrew a net $622M in Q4 2019, closing 304 positions and reducing 219 holdings. Its most notable exit was Celgene Corp, an estimated $224M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 18% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Assenagon Asset Management opened a new position in RTX Corp worth $111M.

  • Assenagon Asset Management's largest Q4 2019 buy was RTX Corp: 1,174,659 shares worth $111M.
  • Assenagon Asset Management added most to Linde in Q4 2019, an estimated $326M increase.
  • Assenagon Asset Management's biggest Q4 2019 reduction was Microsoft, cutting an estimated $654M.
  • Assenagon Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $224M.
  • Assenagon Asset Management's ten largest holdings make up 36% of its $15.9B portfolio in Q4 2019.
  • Assenagon Asset Management opened 237 new positions and closed 304 in Q4 2019.
  • Assenagon Asset Management's portfolio value rose 6.4% quarter-over-quarter to $15.9B.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.